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Systematic Review of Current Evidence
Patterson B.O., Holt P.J.E., Hinchliffe R., Loftus I.M., Thompson M.M.
Eur J Vasc Endovasc Surg 2008;39:637-45.
Objective: To examine and compare existing pre-operative risk predic-
tion methods for elective abdominal aortic aneurysm (AAA) repair.
Design: Systematic review.
Methods:Medline, EMBASE and the Cochrane library were searched
for articles that related to risk predictionmodels used for elective AAA repair.
Results: 680 abstracts were reviewed and after exclusions 28 articles
encompassing 10 risk models were identified. The most frequently studied
of these were the Glasgow Aneurysm Score (GAS), the Physiological and
Operative Severity Score for enUmeration of Mortality (POSSUM) predic-
tor equation and the Vascular Biochemistry and Haematology Outcome
Model (VBHOM). All models had strengths and weaknesses and some had
unique features which were identified and discussed.
Conclusion: The GAS appeared to be the most useful and consistently
validated score at present for open repair. Other systems were either not
validated fully or were not consistently accurate. Some had significant
drawbacks which appeared to severely limit their clinical application. Recent
work has shown that no scores consistently predicted the risk associated with
endovascular aneurysm repair (EVAR). Pre-operative risk stratification is a
vital component of modern surgical practice, and we propose the need for a
comprehensive new risk scoring method for AAA repair incorporating
anatomical and physiological data.
Long-Term Cardiac Outcome in High-Risk Patients Undergoing Elec-
tive Endovascular or Open Infrarenal Abdominal Aortic Aneurysm
Repair
Schouten O., Lever T.M., Welten G.M.J.M., Winkel T.A., Dols L.F.C., Bax
J.J., van Domburg R.T., Verhagen H.J.M., Poldermans D. Eur J Vasc
Endovasc Surg 2008;36:646-52.
Objectives: To assess long-term outcome of patients at high cardiac
risk undergoing endovascular or open AAA repair.
Methods: Patients undergoing open or endovascular infrarenal AAA
repair with 3 cardiac risk factors and preoperative cardiac stress testing
(DSE) at 2 university hospitals were studied. Main outcome was cardiac
event free and overall survival. Multivariate Cox regression analysis was used
to evaluate the influence of type of AAA repair on long-term outcome.
Results: In 124 patients (55 endovascular, 69 open) the number and
type of cardiac risk factors, medication use and DSE results were similar in
both groups. In multivariable analysis, adjusting for cardiac risk factors,
stress test results, medication use, and propensity score endovascular repair
was associated with improved cardiac event free survival (HR 0.54; 95% CI
0.30–0.98) but not with an overall survival benefit (HR 0.73; 95% CI
0.37–1.46). Importantly, statin therapy was associated with both improved
overall survival (HR 0.42; 95% CI 0.21–0.83) and cardiac event free survival
(HR 0.45; 95% CI 0.23–0.86).
Conclusions: The perioperative cardiac benefit of endovascular AAA
repair in high cardiac risk patients is sustained during long-term follow-up
provided patients are on optimal medical therapy but it is not associated with
improved overall long-term survival.
Results of Endovascular Abdominal Aortic Aneurysm Repair with the
Zenith stent-graft
Bos W.T.G.J., Tielliu I.F.J., Zeebregts C.J., Prins T.R., van den Dungen
J.J.A.M., Verhoeven E.L.G. Eur J Vasc Endovasc Surg 2008;36:653-60.
Objective:To evaluate single center results of the Zenith stent-graft for
elective abdominal aortic aneurysm repair.
Methods:Data from all patients treated with a Zenith graft between
March 1999 and December 2006 were retrospectively analyzed from a
prospective database. Outcome measures were technical success, all-
cause and aneurysm related mortality, late complications, and re-inter-
ventions.
Results:A total of 234 patients were included, of which 216weremale.
Mean age was 72.1  6.9 years. Mean diameter of the aneurysm was
60.9  10 mm. Technical success rate was 98.3%. Thirty day mortality was
1.7%. Median follow-up was 26.9 months (range, 1–104). Overall survival
was 92.2  1.8% at 1 year, 87.2  2.3% at 2 years, and 69.9  4.6% at 5
1636years. During follow-up, one aneurysm ruptured due to limb disconnection,
which was treated by bridging stent-grafting. Re-interventions were per-
formed in 9.2% of the patients, with 79% by endovascular means. There was
no mortality related to re-intervention.
Conclusions: Endovascular abdominal aortic aneurysm repair with the
Zenith device provides excellent results with a low risk for aneurysm-related
death and rupture, and a low re-intervention rate in the mid-term.
The Adjuvant Benefit of Angioplasty in Patients with Mild-to-Moder-
ate Intermittent Claudication (MIMIC) Managed by Supervised Exer-
cise, Smoking Cessation Advice and Best Medical Therapy: Results
from Two Randomised Trials for Occlusive Femoropopliteal and Aor-
toiliac Occlusive Arterial Disease
Greenhalgh R.M. Eur J Vasc Endovasc Surg 2008;36:680-8.
Background: Uncertainty exists on whether there is adjuvant benefit
of percutaneous transluminal angioplasty (PTA) over supervised exercise
and best medical therapy in the treatment of intermittent claudication.
Methods: Patients with symptoms of stable mild-to-moderate inter-
mittent claudication (MIMIC) were randomised in two multi-centre trials,
for femoropopliteal and aortoiliac arterial disease, to receive either PTA or
no PTA against a background of supervised exercise and best medical
therapy and followed up for 24 months. Initial claudication distance (ICD)
and absolute walking distance (AWD) on treadmill were compared between
randomised groups adjusting for the corresponding measure at baseline.
Secondary outcomes included ankle-brachial pressure index (ABPI) and
quality of life.
Findings: A total of 93 patients were randomised into the femoropop-
liteal trial (48 into PTA) and 34 into the aortoiliac trial (19 to PTA). The
mean (standard deviation, SD) age was 66(9) years for the femoropopliteal
trial (63% male) and 63(9) for the aortoiliac trial (65% male). At 24 months,
there were significant improvements in both AWD and ICD in the PTA
groups for both trials. The adjusted AWDwas 38% greater in the PTA group
for the femoropopliteal trial (95%; CI 1–90) (p  0.04) and 78% greater in
the PTA group for the aortoiliac trial (95%; CI 0–216) (p  0.05). Further
benefits were demonstrated for ABPI but not for quality of life.
Interpretation: PTA confers adjuvant benefit over supervised exercise
and best medical therapy in terms of walking distances and ABPI 24 months
after PTA in patients with stable MIMIC.
Nordic Poles Immediately Improve Walking Distance in Patients with
Intermittent Claudication
Oakley C., Zwierska I., Tew G., Beard J.D., Saxton J.M. Eur J Vasc
Endovasc Surg 2008;36:689-94.
Objectives: To investigate the immediate effects of Nordic pole walk-
ing (NPW) on walking distance and cardiopulmonary workload in patients
with intermittent claudication.
Methods: Using a standardised treadmill test (3.2 km h1 at 4%
gradient), walking distance, cardiopulmonary responses, leg pain and per-
ceived exertion during NPWwere compared to responses evoked by normal
walking in 20 patients with intermittent claudication. The distance to onset
of claudication pain (claudication distance: CD) and to maximum walking
distance (MWD), heart rate (HR), expired gas parameters, leg pain (Borg’s
CR-10 Scale) and perceived exertion (Borg’s Rating of Perceived Exertion:
RPE Scale) were compared.
Results: CD increased significantly from a median (range) distance of
77 m (28–503) to 130 m (41–1080) andMWD increased significantly from
206 m (81–1078) to 285 m (107–1080) when patients used the Nordic
poles (P  0.000). The level of leg pain at MWD was also significantly
reduced during NPW (P  0.002). Perceived exertion at MWD did not
increase despite an increase in cardiopulmonary work, as indicated by an
increase in oxygen consumption (16.5%; P  0.000).
Conclusion: These results show that NPW immediately enables pa-
tients with intermittent claudication to walk further with less pain, despite a
higher workload. NPWmight be a useful strategy for improving the cardio-
vascular fitness in patients with intermittent claudication.
